Ethypharm SAS Sustainability Profile
Ethypharm SAS, a prominent player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe and beyond. Founded in 2000, the company has established itself as a leader in the development of innovative medicines, particularly in the fields of pain management and critical care. Ethypharm's core offerings include a range of unique drug delivery systems and specialty pharmaceuticals that address unmet medical needs. The company is recognised for its commitment to quality and innovation, which has led to significant milestones, including strategic partnerships and a robust pipeline of products. With a strong market position, Ethypharm continues to make notable contributions to healthcare, enhancing patient outcomes through its specialised therapeutic solutions.
DitchCarbon Score
How does Ethypharm SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ethypharm SAS's score of 31 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ethypharm SAS's reported carbon emissions
Ethypharm SAS, headquartered in France, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As a current subsidiary of Ethypharm SAS, any potential emissions data or climate initiatives may be cascaded from the parent organisation, but no specific details are available regarding such data or initiatives. Ethypharm SAS's commitment to addressing climate change remains unclear, and further information would be necessary to assess their environmental impact and strategies effectively.
How Carbon Intensive is Ethypharm SAS's Industry?
How Carbon Intensive is Ethypharm SAS's Location?
Ethypharm SAS's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ethypharm SAS has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
